Efficacy of renin-angiotensin system (RAS) blockers on cardiovascular and renal outcomes in patients with type 2 diabetes Zemin CaoMark E. Cooper Review Article 25 September 2011 Pages: 243 - 254
Abnormal sleep patterns in subjects with type II diabetes mellitus and its effect on diabetic microangiopathies: Sankara Nethralaya Diabetic Retinopathy Epidemiology and Molecular Genetic Study (SN-DREAMS, report 20) Rajiv RamanAditi GuptaTarun Sharma Original Article 27 November 2010 Pages: 255 - 261
Proliferative retinopathy predicts nephropathy: a 25-year follow-up study of type 1 diabetic patients Charlotte KarlbergChristine FalkJakob Grauslund Original Article 18 June 2011 Pages: 263 - 268
Effects of atorvastatin on apelin, visfatin (nampt), ghrelin and early carotid atherosclerosis in patients with type 2 diabetes Nikolaos P. E. KadoglouNikolaos SailerChristos D. Liapis Original Article 12 July 2011 Pages: 269 - 276
Molecular mechanisms of muscarinic acetylcholine receptor–stimulated increase in cytosolic free Ca2+ concentration and ERK1/2 activation in the MIN6 pancreatic β-cell line Joanne L. SelwayClaire E. MooreTerence P. Herbert Original Article Open access 11 August 2011 Pages: 277 - 289
Angiotensin-(1-7) suppresses oxidative stress and improves glucose uptake via Mas receptor in adipocytes Chang LiuXiao-Hong LvJin-Kui Yang Original Article 01 November 2011 Pages: 291 - 299
Structural damage in diabetic nephropathy is associated with TNF-α system activity José Manuel Fernández-RealJoan VendrellMartí Vallès Original Article 01 November 2011 Pages: 301 - 305
Post-prandial glucose and diabetic complications: systematic review of observational studies Edoardo MannucciMatteo MonamiJohan Erpur Adalsteinsson Original Article 25 November 2011 Pages: 307 - 314
Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy Ying-Zheng ZhaoXing LiMing Zhang Original Article 29 November 2011 Pages: 315 - 325
